With RFK Jr. in charge, supplement makers see chance to cash in

Last fall, before being named the senior U.S. health official, Robert F. Kennedy Jr. said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances — ending the federal agency’s “war on public health,” as he put it.

J&J buys eye disease gene therapy from MeiraGTx, giving the biotech the cash infusion it was seeking

Johnson & Johnson purchased a gene therapy for X-linked retinitis pigmentosa from MeiraGTx for $65 million upfront, the biotech announced Thursday. The deal, which also

December 22, 2023

Augmedix, Andor Health Integrate to Enhance Virtual Care with AI-Powered Documentation

What You Should Know: – Augmedix (AUGX), a leader in AI-powered medical documentation, and Andor Health, a cloud-based platform for virtual care communication, have announced

April 10, 2024

Nestlé divests peanut allergy treatment Palforzia to Stallergenes Greer – Pharmaceutical Technology

Palforzia is an oral immunotherapy that causes desensitisation to certain amounts of allergens by raising the threshold needed for an allergenic reaction. Image Credit: Shutterstock

September 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.